Literature DB >> 9156120

The management of congestive heart failure.

F A McAlister1, K K Teo.   

Abstract

Despite the remarkable advances in cardiovascular therapeutics over the past four decades, little impact has been made on either the incidence or mortality rate of congestive heart failure and it remains a major clinical and public health problem. Recent practice audits have suggested that proven efficacious therapies are not maximally applied in patients with this condition. An approach to the patient with congestive heart failure is presented, emphasizing the two distinct syndromes of systolic dysfunction and diastolic dysfunction. Treatment recommendations are derived from consideration of the underlying pathophysiology and the evidence from randomised clinical trials.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9156120      PMCID: PMC2431272          DOI: 10.1136/pgmj.73.858.194

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  22 in total

Review 1.  Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations.

Authors:  S R Goldsmith; C Dick
Journal:  Am J Med       Date:  1993-12       Impact factor: 4.965

2.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors:  M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

3.  Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.

Authors:  B F Uretsky; J B Young; F E Shahidi; L G Yellen; M C Harrison; M K Jolly
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

Review 4.  Diagnosis and management of heart failure. Canadian Cardiovascular Society.

Authors:  D E Johnstone; A Abdulla; J M Arnold; V Bernstein; M Bourassa; J Brophy; R Davies; M Gardner; R Hoeschen; L Mickleborough
Journal:  Can J Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.223

5.  Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

Authors:  H C Doval; D R Nul; H O Grancelli; S V Perrone; G R Bortman; R Curiel
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

6.  The epidemiology of heart failure: the Framingham Study.

Authors:  K K Ho; J L Pinsky; W B Kannel; D Levy
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

7.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245

8.  The risk of myocardial infarction associated with antihypertensive drug therapies.

Authors:  B M Psaty; S R Heckbert; T D Koepsell; D S Siscovick; T E Raghunathan; N S Weiss; F R Rosendaal; R N Lemaitre; N L Smith; P W Wahl
Journal:  JAMA       Date:  1995 Aug 23-30       Impact factor: 56.272

9.  Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.

Authors:  A M Feldman; M R Bristow; W W Parmley; P E Carson; C J Pepine; E M Gilbert; J E Strobeck; G H Hendrix; E R Powers; R P Bain
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

10.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

Authors:  F Waagstein; M R Bristow; K Swedberg; F Camerini; M B Fowler; M A Silver; E M Gilbert; M R Johnson; F G Goss; A Hjalmarson
Journal:  Lancet       Date:  1993-12-11       Impact factor: 79.321

View more
  4 in total

1.  Management of congestive heart failure.

Authors:  O M Jolobe
Journal:  Postgrad Med J       Date:  1997-12       Impact factor: 2.401

Review 2.  Recent advances in the drug treatment of heart failure.

Authors:  F A McAlister; K K Teo
Journal:  Postgrad Med J       Date:  1998-11       Impact factor: 2.401

Review 3.  Levosimendan.

Authors:  D P Figgitt; P S Gillies; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Skeletal metastasis of carcinoid tumors: Two case reports and review of the literature.

Authors:  Takeshi Hori; Taketoshi Yasuda; Kayo Suzuki; Masahiko Kanamori; Tomoatsu Kimura
Journal:  Oncol Lett       Date:  2012-02-28       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.